Stryker takes preferred equity stake in CMR Surgical for $400 million
SYK•Stryker agreed to invest about $400 million in CMR Surgical through a preferred equity investment, with an exclusive option to acquire all of CMR’s outstanding equity in the future. Stryker will also be the exclusive U.S. sales agent for CMR’s Versius surgical robotics portfolio.
1. Investment and sales agreement
Stryker agreed to invest about $400 million in CMR Surgical through a preferred equity investment. The deal gives Stryker an exclusive option to acquire 100% of CMR’s outstanding equity in the future and makes it the exclusive U.S. sales agent for CMR’s Versius surgical robotics portfolio.
